KMDA Kamada Ltd

  1. Stocks
  2. Healthcare
  3. NASDAQ: KMDA

Price (delayed)

$8.28

Market cap

$477.64M

P/E Ratio

21.79

Dividend/share

$0.42

EPS

$0.38

Enterprise value

$459.97M

?
Relative Growth: Rel. Growth: 61
Relative Strength: Rel. Strength: 59
Relative Valuation: Rel. Valuation: 64
Relative Profitability: Rel. Profitability: 64

Kamada Ltd. (the “Company”) is a vertically integrated global biopharmaceutical company, focused on specialty plasma-derived therapeutics, with a diverse portfolio of marketed products, a robust development pipeline and industry-leading manufacturing ...

Highlights
KMDA's quick ratio is up by 21% since the previous quarter and by 3.6% year-on-year
KMDA's net income is up by 17% year-on-year and by 9% since the previous quarter
The price to earnings (P/E) is 7% higher than the last 4 quarters average of 20.7
KMDA's gross margin is down by 6% year-on-year
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: http://www.kamada.com
Peers: VSTM RGEN ATRA

Key stats

What are the main financial stats of KMDA

KMDA stock price

How has the Kamada stock price performed over time
Intraday
-1.43%
1 week
0.24%
1 month
14.52%
1 year
18.79%
YTD
17.28%
QTD
12.81%

Financial performance

How have Kamada's revenue and profit performed over time
Revenue
$191.85M
Gross profit
$78.31M
Operating income
$27.82M
Net income
$22.25M
Gross margin
40.8%
Net margin
11.6%
KMDA's net income is up by 17% year-on-year and by 9% since the previous quarter
KMDA's revenue is up by 13% year-on-year and by 6% since the previous quarter
Kamada's operating income has increased by 10% YoY and by 10% from the previous quarter
The company's gross profit rose by 6% YoY and by 4.7% QoQ

Price vs fundamentals

How does KMDA's price correlate with its fundamentals

Growth

What is Kamada's growth rate over time

Valuation

What is Kamada stock price valuation
KMDA P/E details
P/E
21.79
P/B
1.77
P/S
2.49
EV/EBIT
16.59
EV/EBITDA
10.69
EV/Sales
2.4
Kamada's EPS has increased by 12% YoY and by 9% QoQ
The price to earnings (P/E) is 7% higher than the last 4 quarters average of 20.7
The stock's price to book (P/B) is 29% more than its 5-year quarterly average of 1.4 and 13% more than its last 4 quarters average of 1.6
KMDA's equity is up by 3.9% since the previous quarter and by 3.7% year-on-year
KMDA's P/S is 20% above its 5-year quarterly average of 2.1 and 10% above its last 4 quarters average of 2.3
KMDA's revenue is up by 13% year-on-year and by 6% since the previous quarter

Efficiency

How efficient is Kamada business performance
Kamada's return on sales has increased by 25% YoY and by 13% QoQ
KMDA's return on equity is up by 14% year-on-year and by 9% since the previous quarter
KMDA's return on assets is up by 12% year-on-year and by 7% since the previous quarter
The company's return on invested capital rose by 10% YoY and by 10% QoQ

Dividends

What is KMDA's dividend history
DPS
$0.42
Dividend yield
5.07%
Payout ratio
110.5%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Kamada financials performed over time
Kamada's current ratio has increased by 22% from the previous quarter
KMDA's quick ratio is up by 21% since the previous quarter and by 3.6% year-on-year
Kamada's debt is 96% less than its equity
KMDA's equity is up by 3.9% since the previous quarter and by 3.7% year-on-year
Kamada's debt has increased by 3.4% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.